WinstonWınston
Omnicell logo

Omnicell

OMCL
47
Information Technology Services · Healthcare
Price
$45.87
-1.13 (-2.40%)
Market Cap
$2.09B
Exchange
NASDAQ
Winston Score
47
Winston is serious
Mixed quality — meaningful strengths and weaknesses.

Share count falling — buybacks

3.3% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 47.9M (2021) → 46.4M (2025)

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing syste

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+14.9% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+266.7% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$88M/ year

Flat (-3% vs prior year)

7.4% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

7.8%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$291M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Omnicell is a rare growth stock that's already generating positive cash flow while growing at 15%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
45.3%
Healthy — 45.3% gross margin
Operating Margin
5.4%
Thin — 5.4% operating margin
ROCE
1.2%
Weak — 1.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+7.9%
Steady sales growth (7.9% YoY)
EPS YoY
-3.6%
Earnings shrinking (-3.6% YoY)

Slight earnings drop. Typical near a cyclical low.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
763%
Turns 763% of profit into real cash
FCF Margin
9.1%
Modest free cash flow (9.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.14
Conservative — low debt load (0.14)
Interest Cover
9.72x
Comfortably covers interest (9.7x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
103.1x
Expensive — P/E 103.1

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+81.7
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (103.1 → 21.4)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial